Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Stahl M, Tallman M. Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all. Leukemia & Lymphoma 2019, 60: 3107-3115. PMID: 31842650, PMCID: PMC7479633, DOI: 10.1080/10428194.2019.1613540.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsArsenic TrioxideDisease-Free SurvivalHemorrhageHumansIncidenceLeukemia, Promyelocytic, AcuteMortalityNeoplasm Recurrence, LocalPractice Guidelines as TopicRandomized Controlled Trials as TopicRemission InductionStandard of CareTime FactorsTretinoinConceptsAcute promyelocytic leukemiaApplication of all-trans retinoic acidArsenic trioxideHigher early death rateHigh-risk acute promyelocytic leukemiaOutcome of high-riskRelapsed APLPromyelocytic leukemiaEarly death rateRelapsed APL patientsTreatment of acute promyelocytic leukemiaAll-Trans Retinoic AcidAPL patientsCare of patientsEarly deathHigh riskPatientsLeukemiaRetinoic acidDeath rate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply